Norris Medicines has informed that the 29th Annual General Meeting (AGM) of the Company was held on 25th September, 2020 through video conferencing, the Company enclosed Voting results as required under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; and Scrutinizers Report on E-voting as per provisions of Section 108 and 109 of the Companies Act, 2013 read with Companies (Management and Administration), Rules, 2014.
The above information is a part of company’s filings submitted to BSE.
